CompletedPhase 2NCT02690025
A Phase 2 Trial Testing ZP1848 in Patients With SBS
Studying Short bowel syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Zealand Pharma
- Principal Investigator
- Gertrud Koefoed Rasmussen, MScZealand Pharma A/S
- Intervention
- ZP1848(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2016 – 2017
Study locations (1)
- Rigshospitalet, Copenhagen, Denmark
Collaborators
Larix A/S
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02690025 on ClinicalTrials.govOther trials for Short bowel syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07319832A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel SyndromeTakeda
- RECRUITINGPHASE3NCT07197944Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBSZealand Pharma
- ENROLLING BY INVITATIONPHASE3NCT07228403Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel SyndromeZealand Pharma
- RECRUITINGPHASE3NCT06973304A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeTakeda
- RECRUITINGPHASE2NCT06904872Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)Napo Therapeutics, S.p.A.
- RECRUITINGNANCT06877923Elemental 028 Extra Case StudiesNutricia UK Ltd
- RECRUITINGEARLY PHASE1NCT06326645Open-Label Pilot Study With Crofelemer in Patients With Short Bowel SyndromeLindsey Russell, MD
- RECRUITINGNCT06771505SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)Hospices Civils de Lyon